Chronic Obstructive Pulmonary Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Obstructive Pulmonary Disease stocks.

Chronic Obstructive Pulmonary Disease Stocks Recent News

Date Stock Title
Mar 28 APGE Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why
Mar 28 AZN Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Mar 28 GTLS Chart Industries Announces the Grand Opening of Its Jumbo Cryogenic Tank Manufacturing Facility in Theodore, Alabama
Mar 28 GYRE Gyre Therapeutics Inc (GYRE) Announces Full Year 2023 Financial Outcomes and Business Progress
Mar 27 AZN Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
Mar 27 GTLS Jim Cramer: Visa Is 'Too Close To All-Time High,' Chart Industries Is 'Absolutely Terrific'
Mar 27 AZN Japan approves AstraZeneca-Sanofi drug for prevention of RSV disease in infants
Mar 26 GYRE Gyre Therapeutics GAAP EPS of -$1.41, revenue of $113.5M
Mar 26 AZN AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication
Mar 26 AZN UPDATE 1-China to speed up 'new productive forces', vice president says
Mar 26 GYRE Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Mar 25 AZN Astrazeneca (AZN) Dips More Than Broader Market: What You Should Know
Mar 25 AZN 31 European Countries That Offer Citizenship by Descent
Mar 25 AZN German industry sceptical of China's vow to treat foreign firms equally
Mar 25 AZN Can Ionis' (IONS) Wholly-Owned Drugs Cut Dependency on Collabs?
Mar 25 DVAX Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68%
Mar 25 APGE Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
Mar 25 AZN ULTOMIRIS® (ravulizumab-cwvz) approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
Mar 25 GTLS Wall Street Thinks This Hydrogen Stock Could Double or Triple, And It Could Be Just The Start
Mar 24 AZN Look beyond the Magnificent 7 to the GRANOLAS - Goldman
Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult. Chronic bronchitis and emphysema are older terms used for different types of COPD. The term "chronic bronchitis" is still used to define a productive cough that is present for at least three months each year for two years.Tobacco smoking is the most common cause of COPD, with factors such as air pollution and genetics playing a smaller role. In the developing world, one of the common sources of air pollution is poorly vented heating and cooking fires. Long-term exposure to these irritants causes an inflammatory response in the lungs, resulting in narrowing of the small airways and breakdown of lung tissue. The diagnosis is based on poor airflow as measured by lung function tests. In contrast to asthma, the airflow reduction does not improve much with the use of a bronchodilator.Most cases of COPD can be prevented by reducing exposure to risk factors. This includes decreasing rates of smoking and improving indoor and outdoor air quality. While treatment can slow worsening, no cure is known. COPD treatments include smoking cessation, vaccinations, respiratory rehabilitation, and often inhaled bronchodilators and steroids. Some people may benefit from long-term oxygen therapy or lung transplantation. In those who have periods of acute worsening, increased use of medications and hospitalization may be needed.As of 2015, COPD affected about 174.5 million (2.4%) of the global population. It typically occurs in people over the age of 40. Males and females are affected equally commonly. In 2015, it resulted in 3.2 million deaths, up from 2.4 million deaths in 1990. More than 90% of these deaths occur in the developing world. The number of deaths is projected to increase further because of higher smoking rates in the developing world, and an aging population in many countries. It resulted in an estimated economic cost of $2.1 trillion in 2010.

Browse All Tags